Biohaven Ltd. (BHVN) has a market capitalization of $1.11B and trades at $10.44. The 52-week range is 7.48-24.06.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.5, Earnings Per Share (EPS) of $-6.86.
The stock has a beta of 3.62, operates in the Healthcare sector.
